Lataa...
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
Phosphatidylinositol 3-kinases (PI3Ks) are lipid kinases that regulate diverse cellular processes including proliferation, adhesion, survival, and motility. Dysregulated PI3K pathway signaling occurs in one-third of human tumors. Aberrantly activated PI3K signaling also confers sensitivity and resis...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3843585/ https://ncbi.nlm.nih.gov/pubmed/24261963 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-6-88 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|